AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 87 of 131

88 Management Table 22. Drugs for Pharmacological Conversion of Atrial Fibrillation to Sinus Rhythm Drug Route of Administration Loading Dose Maintenance Dose Amiodarone IV 5–7 mg/kg or 300 mg* 1200–3000 mg via continuous infusion over 24 h Flecainide Oral † N/A 200 mg if <70 kg, 300 mg if >70 kg, single dose Ibutilide IV ≥60 kg : 1 mg over 10 min <60 kg : 0.01 mg/kg over 10 min If arrhythmia does not terminate within 10 min aer the end of the first infusion, may administer a second dose, equal to the first dose N/A Procainamide IV 1 g over 30 min 2 mg/min continuous infusion over 1 hour Propafenone Oral N/A 450 mg if <70 kg, 600 mg if >70 kg, single dose * Some studies have administered intravenous amiodarone for 24 hours followed by oral administration.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update